US FDA outlines manufacturing-focused stem cell research efforts
US FDA researchers are developing tools to help cell therapy developers improve how they manufacture stem cells in a new lab consortium unveiled by the agency this week.
Archives for August 12, 2014
Health Canada signs off on action plan for GSK flu vaccine plant
Bacterial contamination issues at a GlaxoSmithKline flu vaccine production plant are now being dealt with by an action plan that Health Canada has approved.
Biosimilar firms must be ready for US 'patent dance,' says IP lawyer
The lack of a biopharmaceutical "Orange book" means biosimilar developers face greater litigation risk than their generic counterparts according to one IP lawyer, who says full knowledge of all relevant patents is a must for such firms.